# Study With Improved Solubility Pazopanib

> **NCT02810756** · EARLY_PHASE1 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 12 (actual)

## Conditions studied

- Pharmacokinetics of Pazopanib

## Interventions

- **DRUG:** New Pazopanib formulation

## Key facts

- **NCT ID:** NCT02810756
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-15
- **Primary completion:** 2017-08-28
- **Final completion:** 2017-08-28
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02810756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02810756, "Study With Improved Solubility Pazopanib". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02810756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*